跳至主要内容
临床试验/NCT05464511
NCT05464511尚未招募不适用

Impact of Steerable Delivery Sheaths on Successful Closure of Left Atrial Appendage With AMULET Dual Mechanism Closure Device (STEER-CLOSE Study)

Kansas City Heart Rhythm Research Foundation14 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
300
试验地点
14
主要终点
Need for Pericardiocentesis

研究概览

简要总结

The novel Amplatzer steerable delivery sheath (Abbott Vascular) is found to be safe and effective in performing LAAO procedure. However, the procedural outcomes have not been compared with the traditional non-steerable fixed curve sheath. In this study investigators aim to compare the outcome of patients undergoing left atrial appendage occlusion with the dual mechanism closure Amulet device using non-steerable fixed curve sheath versus a novel steerable sheath.

详细描述

Atrial fibrillation (AF) is the most common abnormal heart rhythm associated with substantial morbidity and mortality. It is one of the strongest risk factors of systemic thromboembolism (TE), with stroke being the most serious outcome. Prevention of stroke is the cornerstone of managing AF, which can be achieved either by oral anticoagulation (OAC) or Percutaneous left atrial appendage occlusion (LAAO) in patients who have a contraindication to OAC. Heterogeneity in cardiac chamber size, interatrial septum, LAA anatomy and orientation, operator experience and currently available fixed curve sheaths add to the complexity of the procedure. Alignment of LAAO device along the access of the left atrial appendage body is an important factor in improving closure rates. The devices which are currently approved by FDA for LAA closure in the U.S. are Amplatzer Amulet device (Abbott Medical) and Watchman and Watchman FLX devices (Boston Scientific). In a recent study, Amplatzer Amulet device was found to be noninferior in terms of safety and effectiveness, with superior LAA occlusion rates but higher device-related complications as compared to first generation watchman device. The LAAO device sheaths that are used currently have fixed shapes and angles that may not be optimal for some LAA anatomy, which can lead to excessive device manipulation, prolonged procedure time, and potentially suboptimal co-axiality during the process. This may lead to increase device related complications. The new Amplatzer steerable delivery sheath (Abbott Vascular) is designed to provide distal bidirectional steerability of the sheath for Amulet implantation. Such steerability may enable successful endovascular closure of greater proportion of LAA, allow precise position of the transseptal puncture, and potentially reduce procedural times and complications with complex cases.

Investigators hypothesize that the use of novel steerable sheath for LAAO closure is safer and more effective as compared to non-steerable fixed curve sheath

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with atrial fibrillation who meets the indication/criteria for left atrial appendage occlusion and undergoing implantation of Amplatzer™ Amulet™ Left Atrial Appendage Occluder device

排除标准

  • Patient been/being implanted with device other than Amplatzer™ Amulet™ Left Atrial Appendage Occluder
  • Pregnant or breastfeeding patients
  • Prisoners
  • Patients not willing to participate in the study

结局指标

主要结局

Need for Pericardiocentesis

时间窗: 7 days

Need for pericardiocentesis within 7 days of implantation

Number of participants with Acute Closure of Left Atrial Appendage

时间窗: 1 day

Acute closure ( less than or equal to 3mm) of the left atrial appendage after Left Atrial Appedage Occlusion(LAAO) procedure

Number of patients with Cardiac Perforation

时间窗: 7 days

Number of patients with cardiac perforation

次要结局

  • Number of participants with Device related thrombus (DRT)(45 days)
  • Number of participants with Transient ischemic attack (TIA) or cerebrovascular accident (CVA)(6 months)
  • Number of devices(1 day (procedure day))
  • Number of device repositions(1 day (procedure day))
  • Closure Rates(45 days)

研究者

发起方
Kansas City Heart Rhythm Research Foundation
申办方类型
Other
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验